The Effect of Unstable Loads on Scapular Kinematics and Muscle Activation During Overhead Press in Overhead Athletes With Subacromial Pain Syndrome

June 9, 2026 updated by: National Yang Ming Chiao Tung University
The research aims to compare the differences between stable and unstable load conditions during shoulder pressing in overhead athletes with SAPS and to compare the differences between SAPS and healthy athletes with stable and unstable load conditions.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
27

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Taiwan
      • Taipei, Taiwan
        • Recruiting
        • National Yang Ming Chiao Tung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Participants were recruited from sports-related venues.

Description

The inclusion criteria for both the experimental and control groups were as follows: (1) amateur or recreational overhead athletes aged 18-40 years (e.g., volleyball, tennis, baseball); (2) sport participation history of more than 3 years; (3) weekly overhead sport participation of more than 4 hours; (4) ability to meet the minimum loading requirements of the equipment for both stable and unstable conditions, defined as a 15-repetition maximum (15RM) for stable shoulder press of ≥10 kg and unstable shoulder press of ≥8 kg.

The individual inclusion criteria for the experimental group were: (1) diagnosis of subacromial pain syndrome, defined as at least 3 positive findings out of 5 clinical tests (Painful Arc test, Neer impingement test, Empty Can test, Hawkins-Kennedy impingement test, and Resisted External Rotation test); (2) Visual Analogue Scale (VAS) score of ≤3 during shoulder press performance; (3) symptoms present on the dominant side.

The individual inclusion criteria for the control group were: absence of shoulder pain within the past 6 months, including no pain at the glenohumeral joint, acromioclavicular joint, sternoclavicular joint, scapulothoracic joint, or cervical spine.

The exclusion criteria were as follows: (1) history of surgical intervention for fracture or dislocation of the shoulder or elbow joint within the past 6 months; (2) direct trauma to the cervical spine or upper extremity within the past 1 month; (3) shoulder pain or neurological symptoms of cervical origin; (4) any condition preventing the completion of the experimental protocol; (5) bilateral shoulder pain.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Control group
Behavioral: stable load shoulder press
Participants performed a shoulder press using a barbell loaded at their individual 15-repetition maximum
Behavioral: Unstable load shoulder press
Participants performed a shoulder press using a unstable loaded at their individual 15-repetition maximum
Experimental group
Behavioral: stable load shoulder press
Participants performed a shoulder press using a barbell loaded at their individual 15-repetition maximum
Behavioral: Unstable load shoulder press
Participants performed a shoulder press using a unstable loaded at their individual 15-repetition maximum

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Scapular kinematics (degrees) during shoulder elevation measured by VIPER™ system
Time Frame: Immediately after the single session
Scapular upward rotation, posterior tilt, and external rotation angles (in degrees) were recorded during shoulder press using the VIPER™ electromagnetic tracking system. Data were collected at 30°, 60°, 90°, and 120° of humeral elevation, and reported as mean values for each angle.
Immediately after the single session
Surface electromyography (TeleMyo2400T G2, Noraxon USA Inc., Scottsdale, AZ, USA)
Time Frame: Immediately after the single session
Muscle activation of upper trapezius, lower trapezius, serratus anterior, anterior deltoid, biceps brachii, triceps brachii, rectus abdominis, erector spinae during shoulder press
Immediately after the single session
Barbell trajectory (measured with camera)
Time Frame: Immediately after the single session
The trajectory was captured by attaching reflective markers to the end of the barbell and recording kinematic data at a sampling frequency of 60 Hz using a camera.
Immediately after the single session

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Shoulder average pain intensity
Time Frame: Immediately after the single session
Pain is measured with Visual Analogue scale (VAS) Score range from 0 to 10. Scoring of 0 represents no pain and scoring of 10 represents pain as bad as it could possibly be.
Immediately after the single session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Yang Ming Chiao Tung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 26, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 9, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 9, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 15, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 15, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 9, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • NYCU113008AF

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Subacromial Pain Syndrome

Clinical Trials on stable load shoulder press

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings